Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI

Clinical trial NCT00406016 · COMPLETED

Trial details

NCT number: NCT00406016
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Spinal Cord Injury

Start date: 2006-05-01
Primary completion: 2011-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.